Japanese
researchers have used CRISPR to remove the extra
chromosome that causes Down syndrome, offering
potential for future therapies — and raising key
ethical questions.
Highlights:
- Japanese scientists used CRISPR to remove the
extra chromosome that causes Down syndrome in
lab-grown cells
- Corrected cells grew faster, had fewer stress
markers, and showed improved biological function
- The technique worked on skin cells from people
with Down syndrome, not just lab cells
Japanese scientists may have rewritten the future of
Down syndrome research by using
gene editing to
remove the extra chromosome that causes the condition.
In a groundbreaking lab study, researchers used the
gene-editing tool
CRISPR-Cas9 to target and
delete the extra copy of
chromosome 21 — the
genetic cause of Down syndrome (
1). The
study, published in PNAS Nexus, is the
first to
demonstrate complete chromosome removal in human
cells. It offers a glimpse into future therapies that
may help manage, or possibly reverse, the biological
effects of Down syndrome.
Did You
Know?
A genetic milestone: Scientists successfully
remove the extra chromosome in Down syndrome cells
using CRISPR-opening new doors for future
research. #downsyndrome #crispr #geneediting
#trisomy21 #medicalbreakthrough #genetics
#chromosomeresearch #medindia
CRISPR in Action: Targeting the Root
of Trisomy 21
Down syndrome, also called
trisomy 21, occurs when a
person has three copies of chromosome 21 instead of two.
This extra DNA causes
developmental delays, heart
defects, and raises the risk for early
Alzheimer's.
The research team, led by Dr. Ryotaro Hashizume at Mie
University, used
CRISPR, a genetic "scissor," to
identify and cut the extra chromosome. Unlike
traditional gene editing, which changes a small section
of DNA, this method aimed to
remove an entire
chromosome.
In lab-grown stem cells, the scientists observed that
removing the extra chromosome normalized gene activity,
especially in genes related to brain development and
metabolism. The edited cells also grew faster, produced
fewer harmful stress chemicals, and had improved energy
function.
Down
syndrome also known as Trisomy 21 is a genetic
disorder caused by the presence of a third copy of
chromosome 21. Down syndrome leads to impairments
in cognitive ability and physical growth of the
...
Real Cells, Real Impact: Beyond the Lab Dish
Importantly, the technique also worked in skin cells
taken from people with Down syndrome. This success
outside of stem cells suggests potential for broader
applications, possibly in future regenerative therapies
to improve organ function.
However, safety concerns remain. Some
CRISPR edits unintentionally
affected healthy DNA, raising the risk of off-target
effects. Researchers are now refining the method to
target only the extra chromosome, ensuring precision.
Top 10 Facts on
Down Syndrome
Down
syndrome or trisomy 21 is a genetic disorder, in
which the affected children usually have an extra
chromosome 21. Here are some interesting facts on
Down syndrome.
A Medical Leap — But Also an Ethical Crossroad
While science moves forward, the idea of removing the
cause of Down syndrome sparks deep ethical debates. In
countries like Iceland, the condition is already rare
due to prenatal screening. Some fear that eliminating
Down syndrome through gene editing
may send harmful messages about the worth and value of
individuals with the condition.
The Japanese team emphasized that their goal is
not
to eliminate Down syndrome from society, but to
understand how gene editing might
reduce health
complications linked to the condition.
CRISPR Gene
Editing Technology
CRISPR
technology allows for precise DNA modifications,
holding promise for treating genetic disorders and
revolutionizing biomedical research.
What’s Next? The Road Ahead
Experts agree: this gene editing isn’t ready for
clinical use. More studies are needed to ensure safety,
especially long-term monitoring of edited cells.
Scientists also want to explore whether corrected cells
could be used in future cell therapies for the heart,
brain, or
immune system.
Most importantly, any future treatment would need
careful public discussion, including the voices of
people with Down syndrome and their families.
Final Takeaway: Science, Hope, and Humanity
Intertwined
This breakthrough shows how far science can go, from
editing single genes to removing whole chromosomes. It
brings hope for better health outcomes for people with
Down syndrome. But it also reminds us to ask not just
what we can do, but what we should do. As gene editing
advances, thoughtful dialogue between science and
society will shape what comes next.
Reference:
- Trisomic rescue via allele-specific multiple
chromosome cleavage using CRISPR-Cas9 in trisomy 21
cells - (https://academic.oup.com/pnasnexus/article/4/2/pgaf022/8016019?login=f